Lee Flowers serves as Executive at HCW Biologics Inc., where they oversee executive responsibilities. Since joining the company, Lee Flowers has executed 10 insider transactions totaling $415.7K, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 20, 2024 involved receiving (via award) 71,429 shares valued at $100.0K.
Lee Flowers currently holds 190,238 shares of HCW Biologics Inc. (HCWB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Lee Flowers has been a net buyer of HCWB stock. They have purchased $415.7K and sold $0 worth of shares.
Lee Flowers's most recent insider trade was on Feb 20, 2024, when they sold 71,429 shares at $1.40 per share.
Get notified when new Form 4 filings are submitted
| 7,501 |
| $0.14 |
| Discretionary |
| Jun 8, 2023 | HCWB | $750 | Option Exercise | 5,356 | $0.14 | Discretionary |
| Jun 8, 2023 | HCWB | $21.6K | Purchase | 10,000 | $2.16 | Discretionary |
| Dec 1, 2021 | HCWB | $600 | Option Exercise | 4,285 | $0.14 | Discretionary |
| Aug 23, 2021 | HCWB | $22.1K | Purchase | 5,605 | $3.95 | Discretionary |
| Aug 20, 2021 | HCWB | $32.0K | Purchase | 7,853 | $4.08 | Discretionary |
| Aug 19, 2021 | HCWB | $44.8K | Purchase | 10,532 | $4.25 | Discretionary |
| Aug 19, 2021 | HCWB | $45.2K | Purchase | 10,532 | $4.29 | Discretionary |
| Jul 22, 2021 | HCWB | $250.0K | Purchase | 31,250 | $8.00 | Discretionary |